Mizuho analyst Vikram Malhotra maintains Boston Properties (NYSE:BXP) with a Buy and lowers the price target from $135 to $105.
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a